Benefits of genetic testing: Following the standard guidelines, every patient exhibiting clinical signs of MEN1 syndrome should undergo testing for pathogenic variants of MEN1 and RET (ret proto-oncogene). Here, RET is linked to multiple endocrine neoplasia type 1.